期刊文献+

全胸腔镜肺叶切除手术治疗非小细胞肺癌的临床效果观察

Clinical effect of total thoracoscopic lobectomy in the theatment of non-small cell lung cancer
下载PDF
导出
摘要 目的:分析全胸腔镜肺叶切除手术治疗非小细胞肺癌的临床效果.方法:选取非小细胞肺癌患者50例,按手术方法不同分为两组.对照组采用传统开胸手术治疗;观察组采用全胸腔镜肺叶切除手术治疗.对比两组各项临床指标水平及术后疼痛程度.结果:观察组围手术期各项临床指标水平均显著优于对照组,差异有统计学意义(P<0.05);观察组术后疼痛程度显著低于对照组,差异有统计学意义(P<0.05).结论:应用全胸腔镜肺叶切除手术治疗非小细胞癌,可有效改善患者多项临床症状,降低术后疼痛程度. Objective:To explore the clinical effect of total thoracoscopic lobectomy in the theatment of non-small cell lung cancer.Methods:Fifty patients with non-small cell lung cancer were selected and divided into two groups according to different surgical methods.The control group was treated with traditional thoracotomy,and the observation group was treated with total thoracoscopic lobectomy.We compared the levels of clinical indicators and postoperative pain between the two groups.Results:In the observation group,the level of clinical indicators in the perioperative period was significantly better than that in the control group,the difference was statistically significant(P<0.05).The degree of postoperative pain in the observation group was significantly lower than that in the control group,the difference was statistically significant(P<0.05).Conclusion:The application of total thoracoscopic lobectomy in the treatment of non-small cell carcinoma can effectively improve the clinical symptoms and reduce the degree of postoperative pain.
作者 孙毅 Sun Yi(Thoracic Surgery,Pei County People's Hospital,Xuzhou City,Jiangsu Province Jiangsu Xuzhou221600)
出处 《中国社区医师》 2019年第35期20-21,共2页 Chinese Community Doctors
关键词 全胸腔镜肺叶切除手术 非小细胞肺癌 传统开胸手术 Total thoracoscopic lobectomy Non-small cell lung cancer Traditional thoracotomy
  • 相关文献

参考文献4

二级参考文献64

  • 1郝捷,陈万青(主编).中国肿瘤登记年报(2012)[M].北京:军事医学科学出版社,2012.12-30.
  • 2WHO. Globoean 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012 [EB/OL]. [2015437-06]. http :// globocan, iarc. fr/Pages/online, aspx.
  • 3Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer [J]. Nature, 2007, 448(7153):561-566.
  • 4Wong DW, Leung EL, So KK, et al. The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS [J]. Cancer, 2009, 115(8) :1723-1733.
  • 5Shackelford RE, Vora M, Mayhall K, et al. ALK-rearrangements and testing methods in non-small cell lung cancer : a review [J]. Genes Cancer, 2014, 5(1-2):1-14.
  • 6Vidal J, Clav S, de Muga S, et al. Assessment of ALK status by FISH on 1000 Spanish non-small cell lung cancer patients[J]. J Thorac Oneol, 2014, 9(12):1816-1820.
  • 7Pan Y, Zhang Y, Li Y, et al. ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features[J]. Lung Cancer, 2014, 84 (2) : 121-126.
  • 8Shaw AT, Kim DW, Mehra R, et al. Ceritinib in ALK-rearranged non-small-cell lung cancer[J]. N Engl J Med, 2014, 370 ( 13 ) : 1189-1197.
  • 9Solomon BJ, Mok T, Kim DW, et al. First-line crizotinib versus chemotherapy in ALK-positive lung cancer [J]. N Engl J Med, 2014, 371 (23) :2167-2177.
  • 10Shaw AT, Kim DW, Nakagawa K, et al. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer[J]. N Engl J Med, 2013, 368(25):2385-2394.

共引文献129

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部